Trump Gets Experimental Treatment With Synthetic Antibodies | Abroad

Trump would have “ mild complaints, ” the White House reported Friday. At 74 years old, he belongs to the risk groups.

The experimental treatment would consist of the administration of synthetic antibodies. This is considered very promising, according to one of the specialists involved. Trump also takes zinc, vitamin D, famotidine – an anti-heartburn agent – melatonin and “a daily aspirin,” the White House said in an official press release.

Trump remains ‘tired but cheerful’. “He is watched by a team of experts and together we make recommendations on next steps,” also for his wife Melania, it is reported.

Melania Trump is reported to be ‘making it up to just a light cough and headache’.

Medicines Trump

The synthetic antibodies are produced by the Regeneron company and are currently still under investigation, including in Phase 3. Three days ago the preliminary results were shared. Company President Dr. George Yancopoulos was “incredibly grateful” with the results. The drug has not yet been approved by the FDA. Those steps have yet to be taken. Once successful, Regeneron will market the drug in the US and pharmaceutical giant Roche in the rest of the world.

Donald Trump is therefore not currently taking hydroxychloroquine, the malaria drug he previously took as a preventive measure, according to his official spokespersons.

–